
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Gatifloxacin labels and packages
Introduction
| Gatifloxacin |
|---|
| GATIFLOXACIN®,ZYMAXID®,ZYMAR® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Clinical Studies |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
For patient information, click here.
© 2012 Allergan, Inc. Irvine, CA 92612, U.S.A. ® marks owned by Allergan, Inc. Licensed from Kyorin Pharmaceuticals Co., Ltd. U.S. Patents 5,880,283 and 6,333,045
Made in the U.S.A.
72366US11C
Principal Display Panel
Package Label – 2.5 mL Carton Label
NDC 0023-3615-25
Zymaxid®
(gatifloxacin ophthalmic solution) 0.5%
2.5 mL
Rx only sterile
ALLERGAN®
![]() |
References
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1160b16c-929a-4e85-9c0b-1d8c96a7678b
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

